» Authors » Mohanapriya Arumugam

Mohanapriya Arumugam

Explore the profile of Mohanapriya Arumugam including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 18
Citations 79
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Eshak D, Arumugam M
Comput Biol Chem . 2024 Sep; 113:108211. PMID: 39299050
Amyotrophic lateral sclerosis (ALS), commonly known as Lou Gehrig's disease, is a debilitating neurodegenerative disorder characterized by the progressive degeneration of nerve cells in the brain and spinal cord. Despite...
2.
Ahmad F, Sudesh R, Ahmed A, Arumugam M, Mathkor D, Haque S
Expert Rev Mol Med . 2024 Apr; 26:e11. PMID: 38682637
Long non-coding RNAs (lncRNAs) are progressively being perceived as prominent molecular agents controlling multiple aspects of neuronal (patho)physiology. Amongst these is the HOX transcript antisense intergenic RNA, often abbreviated as...
3.
Choudhury A, Arumugam M, Ponnusamy N, Sivaraman D, Sertsemariam W, Thiruvengadam M, et al.
J Biomol Struct Dyn . 2024 Feb; :1-15. PMID: 38334124
Diabetes mellitus (DM) is a multifactorial life-threatening endocrine disease characterized by abnormalities in glucose metabolism. It is a chronic metabolic disease that involves multiple enzymes such as α-amylase and α-glucosidases....
4.
Dhamodharan P, Pillai G, Arumugam M
J Biomol Struct Dyn . 2023 Oct; 42(20):10994-11019. PMID: 37811632
COPD is a multifactorial lung disease causing breathing difficulties in individuals and is becoming a major health concern worldwide. The unclear pathogenic mechanism and high mortality rate urge the development...
5.
Saha P, Panda S, Holkar A, Vashishth R, Rana S, Arumugam M, et al.
Ageing Res Rev . 2023 Sep; 91:102056. PMID: 37673131
Agmatine, an endogenous polyamine derived from L-arginine, elicits tremendous multimodal neuromodulant properties. Alterations in agmatinergic signalling are closely linked to the pathogeneses of several brain disorders. Importantly, exogenous agmatine has...
6.
Ponnusamy N, Pillai G, Arumugam M
J Biomol Struct Dyn . 2023 May; 42(7):3382-3395. PMID: 37211911
Tuberculosis (TB) is still one of the world's most challenging infectious diseases and the emergence of drug-resistant poses a significant threat to the treatment of TB. Identifying new medications based...
7.
Ponnusamy N, Arumugam M
Front Cell Infect Microbiol . 2022 Oct; 12:1010771. PMID: 36275035
Multi-drug resistant tuberculosis still remains a major public health crisis globally. With the emergence of newer active tuberculosis disease, the requirement of prolonged treatment time and adherence to therapy till...
8.
Ponnusamy N, Arumugam M
Infect Disord Drug Targets . 2021 Sep; 22(2):e130921196420. PMID: 34517809
Tuberculosis (TB), an infectious disease caused by Mycobacterium tuberculosis (Mtb), infects the lungs' alveolar surfaces through aerosol droplets. At this stage, the disease progression may have many consequences, determined primarily...
9.
Dhamodharan P, Arumugam M
COPD . 2020 Aug; 17(6):684-698. PMID: 32757672
Chronic obstructive pulmonary disease is a complex pulmonary disease that causes airflow obstruction in humans. To identify the core genes in COPD pathogenesis, seven diverse microarray datasets (GSE475, GSE1122, GSE1650,...
10.
Odumpatta R, Arumugam M
J Mol Neurosci . 2020 Jul; 71(3):466-480. PMID: 32728898
Parkinson's disease (PD) is a progressive neurodegenerative disease affecting the ventral midbrain dopaminergic neurons, resulting in motor defects mainly tremor, rigidity, and bradykinesia along with a wide array of non-motor...